CDKN2A and lymphoma: Similar to previous reports [21], Ink4a/Arf+/− mice developed lymphoma and fibrosarcoma and we found that overexpression of TYMS resulted in a higher incidence of these tumors in hTS/Ink4a/Arf+/- mice (Fig. 1C).